Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HOME DEPOT, INC.HD · Entity 2816 | Director | May 18, 2017 | May 22, 2017 |
| L3HARRIS TECHNOLOGIES, INC. /DE/HRS · Entity 610 | Director | October 01, 2016 | October 04, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HOME DEPOT, INC.
Report date May 18, 2017 · Filed May 22, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred SharesSEC Table II · derivative / convertible security | Direct | 65,950.8062 |
Reported balance
After 2017-05-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-05-18 · Grant · Acquired 1,477.1997 · Balance 65,950.8062 F1: The Deferred Shares were granted under The Home Depot, Inc. Amended and Restated 2005 Omnibus Stock Incentive Plan and convert to shares of Common Stock on a one-for-one basis upon the earliest of (i) the first anniversary of the director's termination of service as a Board member, (ii) the date of the director's death, retirement or disability, or (iii) the date of a change in control of the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: The Deferred Shares were granted under The Home Depot, Inc. Amended and Restated 2005 Omnibus Stock Incentive Plan and convert to shares of Common Stock on a one-for-one basis upon the earliest of (i) the first anniversary of the director's termination of service as a Board member, (ii) the date of the director's death, retirement or disability, or (iii) the date of a change in control of the Company.
L3HARRIS TECHNOLOGIES, INC. /DE/
Report date October 01, 2016 · Filed October 04, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 88,228.58 |
Reported balance
After 2016-10-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2016-10-01 · Grant · Acquired 368.41 · Balance 88,228.58 F1: Each phantom stock unit is the economic equivalent of one share of the Issuer's common stock. F2: The phantom stock units were awarded on October 1, 2016 pursuant to an automatic quarterly grant under the Harris Corporation 2005 Directors' Deferred Compensation Plan. The phantom stock units are to be settled in cash upon the reporting person's retirement or other events. The reporting person may also transfer the phantom stock units into alternative investment accounts in certain other instances if applicable ownership guidelines are satisfied. F3: The aggregate of 88,228.58 phantom stock units includes: (a) 1,594.56 phantom stock units acquired through dividend reinvestment in the Harris Corporation Directors' Deferred Compensation Plans ("Plans") from 3/8/16 through 9/7/16 and (b) a reduction of a .19 phantom stock unit due to rounding of previous reports by the Plans' record keeper. |
Filing footnotes · ownership attribution and instrument terms
F1: Each phantom stock unit is the economic equivalent of one share of the Issuer's common stock.
F2: The phantom stock units were awarded on October 1, 2016 pursuant to an automatic quarterly grant under the Harris Corporation 2005 Directors' Deferred Compensation Plan. The phantom stock units are to be settled in cash upon the reporting person's retirement or other events. The reporting person may also transfer the phantom stock units into alternative investment accounts in certain other instances if applicable ownership guidelines are satisfied.
F3: The aggregate of 88,228.58 phantom stock units includes: (a) 1,594.56 phantom stock units acquired through dividend reinvestment in the Harris Corporation Directors' Deferred Compensation Plans ("Plans") from 3/8/16 through 9/7/16 and (b) a reduction of a .19 phantom stock unit due to rounding of previous reports by the Plans' record keeper.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
IMS Health Holdings, Inc.
Report date October 03, 2016 · Filed October 03, 2016
Section 16 reporting ended · disclosed 2016-10-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2016-10-03 transaction · row 1
1 source rowRow 1 · 2016-10-03 · Disposition to issuer · Disposed 11,633 · Balance 0 F1: On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. ("Quintiles") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the "merger"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc. F2: Disposed of pursuant to merger agreement in exchange for 4,467 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. ("Quintiles") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the "merger"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc.
F2: Disposed of pursuant to merger agreement in exchange for 4,467 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger.
PFIZER INC
Report date August 15, 2006 · Filed August 17, 2006
Section 16 reporting ended · disclosed 2006-08-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock Units SSPSEC Table II · derivative / convertible security | Direct | 39,665 |
Reported balance
After 2006-08-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2006-08-15 · Grant · Acquired 444 · Balance 39,665 F1: Each unit represents one phantom share of common stock. F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit represents one phantom share of common stock.
F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2003 Filed Dec 16, 2003 18:49 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 62 | $34.44 | $2,135.28 |
DisclosureSEC source: 0000078003-03-000312 · kat537.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,314 Underlying: Common Stock · 62 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 26, 2003 Filed Dec 1, 2003 18:25 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 61 | $33.83 | $2,063.63 |
DisclosureSEC source: 0000078003-03-000299 · kat525.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,252 Underlying: Common Stock · 61 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| November 20, 2003 Filed Nov 24, 2003 16:01 UTC | PFIZER INC PFE · Entity 2863 | GiftCommon Stock | 466 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-03-000294 · kat520.xml · nonDerivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 639,212 Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:40 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 64,800 | $0.00 Strike: $8.17 | $0.00 |
DisclosureSEC source: 0000078003-03-000291 · kat517.xml · derivative · entry 4 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,800 shares Expires 2005-08-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable in 5 equal annual installments beginning on August 24, 1996. Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:40 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 64,800 | $34.37 | $2,227,176.00 |
DisclosureSEC source: 0000078003-03-000291 · kat517.xml · nonDerivative · entry 2 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 639,678 Read SEC document |
| November 18, 2003 Filed Nov 19, 2003 18:40 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 64,800 | $8.17 | $529,416.00 |
DisclosureSEC source: 0000078003-03-000291 · kat517.xml · nonDerivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 704,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 18:30 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 171 | $34.08 | $5,827.68 |
DisclosureSEC source: 0000078003-03-000283 · kat510.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,191 Underlying: Common Stock · 171 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 31, 2003 Filed Nov 4, 2003 16:01 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 62 | $31.60 | $1,959.20 |
DisclosureSEC source: 0000078003-03-000258 · kat499.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,020 Underlying: Common Stock · 62 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| October 15, 2003 Filed Oct 16, 2003 15:47 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 70 | $30.60 | $2,142.00 |
DisclosureSEC source: 0000078003-03-000238 · kat488.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,958 Underlying: Common Stock · 70 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 30, 2003 Filed Oct 1, 2003 15:57 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 69 | $30.38 | $2,096.22 |
DisclosureSEC source: 0000078003-03-000221 · kat459.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,888 Underlying: Common Stock · 69 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| September 15, 2003 Filed Sep 16, 2003 15:31 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 56 | $31.86 | $1,784.16 |
DisclosureSEC source: 0000078003-03-000202 · kat432.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,819 Underlying: Common Stock · 56 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 29, 2003 Filed Sep 2, 2003 19:18 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 79 | $29.92 | $2,363.68 |
DisclosureSEC source: 0000078003-03-000186 · kat428.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,763 Underlying: Common Stock · 79 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| August 15, 2003 Filed Aug 18, 2003 19:20 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 190 | $31.42 | $5,969.80 |
DisclosureSEC source: 0000078003-03-000176 · kat412.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,684 Underlying: Common Stock · 190 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| July 31, 2003 Filed Aug 4, 2003 16:29 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 62 | $33.36 | $2,068.32 |
DisclosureSEC source: 0000078003-03-000161 · kat401.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,494 Underlying: Common Stock · 62 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| July 15, 2003 Filed Jul 16, 2003 19:10 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 62 | $33.86 Strike: $0.00 | $2,099.32 |
DisclosureSEC source: 0000078003-03-000142 · kat388.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,432 Underlying: Common Stock · 62 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| June 30, 2003 Filed Jul 2, 2003 15:27 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 57 | $34.15 Strike: $0.00 | $1,946.55 |
DisclosureSEC source: 0000078003-03-000128 · kat377.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,370 Underlying: Common Stock · 57 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| June 13, 2003 Filed Jun 16, 2003 19:15 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 52 | $33.08 Strike: $0.00 | $1,720.16 |
DisclosureSEC source: 0000078003-03-000081 · kat356.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,313 Underlying: Common Stock · 52 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 30, 2003 Filed Jun 2, 2003 18:02 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 79 | $31.02 Strike: $0.00 | $2,450.58 |
DisclosureSEC source: 0000078003-03-000068 · kat347.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,261 Underlying: Common Stock · 79 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 15, 2003 Filed May 16, 2003 17:39 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 169 | $33.53 Strike: $0.00 | $5,666.57 |
DisclosureSEC source: 0000078003-03-000057 · kat333.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,182 Underlying: Common Stock · 169 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.